Hypertension adversely
affects the quality of life in humans across
modern society. Studies have attributed increased reactive oxygen
species production to the pathophysiology of hypertension. So far,
a specific drug to control the disease perfectly has not been developed.
However, artichoke, an edible vegetable, plays an essential role in
treating many diseases due to its potent antioxidant activities. The
objective of this study is to evaluate the effect of artichoke bud
extract (ABE) on heart tissue metabolomics of hypertensive rats. Spontaneously
hypertensive rats and Wistar–Kyoto (WKY) rats were divided
into six groups, then exposed to different doses comprising ABE, Enalapril
Maleate, or 1% carboxylmethyl cellulose for 4 weeks. Their blood pressures
were recorded at 0, 2, 3, and 4 weeks after the start of the test
period. Thereafter, all rats were anesthetized, and blood was collected
from their cardiac apexes. Then, we measured the levels for 15 kinds
of serum biochemical parameters. An established orthogonal partial
least square-discriminant analysis model completed the metabolomic
analysis. Hypertensive rats in the ABE group exhibited well-controlled
blood pressure, relative to those in the model group. Specifically,
artichoke significantly lowered serum levels for total protein (TP),
albumin (ALB), and uric acid (UA) in the hypertensive rats. This effect
involved the action of eight metabolites, including guanine, 1-methylnicotinamide, p-aminobenzoic acid, NAD, NADH, uridine 5′-monophosphate,
adenosine monophosphate, and methylmalonic acid. Collectively, these
findings suggest that ABE may play a role in affecting oxidative stress
and purine, nicotinate, and nicotinamide metabolism.